Reliable dsRNA Removal: A Purity Milestone for mRNA/LNP Manufacturing

Reliable dsRNA Removal: A Purity Milestone for mRNA/LNP Manufacturing
Category: Technology
72
1 month ago

The success of mRNA-based vaccines has established messenger RNA (mRNA) as an important therapeutic platform, with continued development across infectious diseases, oncology and other therapeutic areas. As manufacturers and biotechnology companies in Türkiye and the wider region evaluate mRNA and lipid nanoparticle (LNP) manufacturing capabilities, downstream purification and impurity control remain important considerations for process development.

Among the impurities associated with in vitro transcription (IVT), double-stranded RNA (dsRNA) is a critical impurity to control due to its potential to activate unwanted innate immune responses and affect product quality.

Why dsRNA Matters

dsRNA can be generated as a by-product of the in vitro transcription process used to produce mRNA. Effective removal of dsRNA is therefore an important part of the purification strategy for mRNA drug substance.

A robust and reproducible dsRNA clearance step can support consistent product quality and help manufacturers establish a downstream process suitable for scale-up and future GMP manufacturing.

An Affinity-Based Approach to dsRNA Removal

Repligen’s AVIPure™ dsRNA Clear OPUS® columns are designed for the removal of dsRNA using bead-based affinity chromatography operated in flow-through mode. The technology is designed to selectively capture dsRNA while allowing the target single-stranded RNA (ssRNA) to pass through the column.

Key features of the technology include:

  • Targeted removal of dsRNA impurities while supporting ssRNA recovery

  • Solvent-free operation, eliminating the need for organic solvents such as ethanol in this purification step

  • Pre-packed OPUS® column formats designed to facilitate process development and scale-up

For further technical information, refer to Repligen’s AVIPure™ dsRNA Clear Resin product documentation.

Process Considerations for mRNA/LNP Manufacturing

For biotechnology companies and contract manufacturers developing mRNA-based processes, the integration of an effective dsRNA clearance step can contribute to a streamlined downstream purification strategy.

A solvent-free purification approach may simplify process operation and reduce considerations associated wi

Search for a city or select popular from the list
Share
Click on the image to refresh the captcha.